Results 161 to 170 of about 2,779 (193)

Discovery and biological confirmation of a highly divergent Tacaribe virus in metatranscriptomic data from neotropical bats. [PDF]

mSphere
Fischer C, Anzolini Cassiano MH, Thomas WR, Dávalos LM, Leon Y, Salazar J, Rossiter SJ, Moreira-Soto A, Drexler JF.   +8 more
europepmc   +1 more source

The detection of lymphocytic choriomeningitis virus sampled on illegal waste sites in Istria peninsula [PDF]

, 2015
Hasić, Sandra
core   +1 more source

Coadministration of LHF-535 and favipiravir protects against experimental Junín virus infection and disease. [PDF]

Antiviral Res
Westover JB, Bailey KW, Wasson SR, Boardman KM, Lustig KH, Amberg SM, Gowen BB.   +6 more
europepmc   +1 more source

Self-Replicating Alphaviruses: From Pathogens to Therapeutic Agents. [PDF]

Viruses
Lundstrom K.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Epidemiology of Machupo Virus Infection

American Journal of Tropical Medicine and Hygiene, 1965
Summary The localities in Bolivia from which cases of hemorrhagic fever have been reported are farming communities with characteristic ecological features. The rodent, Calomys callosus, is an important reservoir host of the Machupo virus. An experimental program of disease control was successfully carried out in San Joaquin, Beni, Bolivia.
exaly   +10 more sources

Bivalent Junin & Machupo experimental vaccine based on alphavirus RNA replicon vector

Vaccine, 2020
Junin (JUNV) and Machupo (MACV), two mammalian arenaviruses placed on the 2018 WHO watch list, are prevalent in South America causing Argentine and Bolivian hemorrhagic fevers (AHF and BHF), respectively. The live attenuated JUNV vaccine, Candid #1, significantly reduced the incidence of AHF.
Dylan M Johnson, Ricardo Carrion Jr, Igor S Lukashevich   +2 more
exaly   +3 more sources

Unusual Molecular Architecture of the Machupo Virus Attachment Glycoprotein [PDF]

Journal of Virology, 2009
ABSTRACTNew World arenaviruses, which cause severe hemorrhagic fever, rely upon their envelope glycoproteins for attachment and fusion into their host cell. Here we present the crystal structure of the Machupo virus GP1 attachment glycoprotein, which is responsible for high-affinity binding at the cell surface to the transferrin receptor.
Thomas A Bowden, Max Crispin, David J Harvey   +2 more
exaly   +4 more sources

Chronic Infection of Rodents by Machupo Virus

Science, 1965
Machupo virus, the etiologic agent of human hemorrhagic fever in Bolivia, induced chronic asymptomatic infection in laboratory hamsters and colonized individuals of the peridomestic, wild, South American rodent, Calomys callosus . Viruria was detected for more than 500 and 150 days, respectively, in the two species.
K M, Johnson, R B, Mackenzie, P A, Webb, M L, Kuns   +3 more
exaly   +3 more sources

Machupo virus polypeptides: Identification by immunoprecipitation

Archives of Virology, 1985
The most abundant protein in purified Machupo virions (Corvallo strain) labelled with 14C-Protein hydrolysate is a 64 K polypeptide which is associated with virion RNAs. Another structural polypeptide, 37 K, solubilized by nonionic detergent seems to be a major surface glycoprotein.
I S, Lukashevich, N N, Lemeshko
openaire   +2 more sources

Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses [PDF]

Expert Opinion on Drug Discovery, 2012
Seven arenaviruses cause viral hemorrhagic fever in humans: the Old World arenaviruses Lassa and Lujo, and the New World Clade B arenaviruses Machupo (MACV), Junín (JUNV), Guanarito (GTOV), Sabiá (SABV), and Chapare (CHPV). All of these viruses are Risk Group 4 biosafety pathogens. MACV causes human disease outbreak with high case-fatality rates.
Jens H Kuhn, Peter B Jahrling, Sina Bavari   +2 more
exaly   +3 more sources